EO9: a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models (Q41579896)
Jump to navigation
Jump to search
scientific article published on January 1993
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | EO9: a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models |
scientific article published on January 1993 |
Statements
1 reference
EO9: a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models (English)
1 reference
Hendriks HR
1 reference
Pizao PE
1 reference
Berger DP
1 reference
Kooistra KL
1 reference
Bibby MC
1 reference
Boven E
1 reference
Dreef-van der Meulen HC
1 reference
Henrar RE
1 reference
Fiebig HH
1 reference
Double JA
1 reference
1 January 1993
1 reference
1 reference
29A
1 reference
6
1 reference
897-906
1 reference
Identifiers
1 reference
1 reference